Markets:

Overview

News

Currencies

International

Treasuries

Crescent Biopharma, Inc. - Common Stock (NQ:CBIO)

18.07 -4.30 (-19.22%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Crescent Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 01, 2023

Via Benzinga

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 01, 2023

It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 28, 2023

Via Benzinga

Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 28, 2023

Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 28, 2023

Via Benzinga

Catalyst Biosciences Shares Are Rallying: What's Driving The Action? ↗

February 28, 2023

Catalyst Biosciences Inc (NASDAQ: CBIO) shares are soaring Tuesday morning after GC Biopharma signed an Asset Purchase Agreement with the c

Via Benzinga

Why Is AdaptHealth (AHCO) Stock Down 22% Today? ↗

February 28, 2023

AdaptHealth (AHCO) stock is falling on Tuesday following the release of the company's earnings report for the fourth quarter of 2022.

Via InvestorPlace

Why Is Aptinyx (APTX) Stock Down 64% Today? ↗

February 28, 2023

Aptinyx (APTX) stock is taking a beating on Tuesday after the company revealed poor results from a Phase 2 clinical trial.

Via InvestorPlace

Why Is Intelligent Living (ILAG) Stock Up 38% Today? ↗

February 28, 2023

Intelligent Living (ILAG) stock is heading higher on Tuesday after the company announced plans to develop home security devices.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 28, 2023

Via Benzinga

Why Is Catalyst Biosciences (CBIO) Stock Up 55% Today? ↗

February 28, 2023

Catalyst Biosciences (CBIO) stock is rocketing higher on Tuesday after the company agreed to an asset purchase agreement with GC Biopharma.

Via InvestorPlace

Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket ↗

February 28, 2023

Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 28, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 02, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

Why First Wave BioPharma Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗

January 17, 2023

Gainers Celyad Oncology SA (NASDAQ: CYAD) rose 221.7% to $2.57 in pre-market trading after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 16, 2023

Via Benzinga

Nasdaq Up 50 Points; Gold Rises Over 1% ↗

January 13, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 13, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 13, 2023

We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

CATALYST BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Catalyst Biosciences, Inc. - CBIO

December 30, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

CBIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Catalyst Biosciences, Inc. Is Fair to Shareholders

December 28, 2022

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 21, 2022

We're starting Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!

Via InvestorPlace

How Is The Market Feeling About Catalyst Biosciences? ↗

September 02, 2022

Catalyst Biosciences's (NASDAQ:CBIO) short percent of float has fallen 48.42% since its last report. The company recently reported that it has 918 thousand shares sold short,...

Via Benzinga

JDS1, LLC Terminates Proxy Contest at Catalyst’s 2022 Annual Meeting

August 11, 2022

From JDS1, LLC

Via Business Wire

JDS1, LLC Files Definitive Proxy Statement and Sends Letter to Catalyst Stockholders

July 22, 2022

From JDS1, LLC

Via Business Wire

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗

June 30, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Crescent Biopharma, Inc. - Common Stock (NQ:CBIO)

All News about Crescent Biopharma, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today